Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer

被引：0
|
作者：
Ohba, Akihiro
Takashima, Atsuo
Nishiuchi, Takamasa
Honma, Yoshitaka
Iwasa, Satoru
Okita, Natsuko
Kato, Ken
Hamaguchi, Tetsuya
Nagashima, Kengo
Boku, Narikazu
机构：
[1] Natl Canc Ctr, Gastrointestinal Med Oncol, 1-1 Tsukiji 5 Chome, Tokyo, Japan
[2] Kagawa Univ, Fac Med, Dept Clin Oncol, Kagawa, Japan
[3] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Ryo Otsuka
    Satoru Iwasa
    Takako Yanai
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Hironobu Hashimoto
    Masatoshi Sekiguchi
    Yoshinori Makino
    Narikazu Boku
    Masakazu Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 595 - 601
  • [32] Second-line chemoterapy in advanced gastric cancer patients
    Belloni, P.
    Cozzi, C.
    Toniolo, D.
    Zannier, F.
    Candido, P.
    Della Torre, S.
    Corradini, G. M.
    Bollina, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 103 - 103
  • [33] Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer
    Fujii, Hironori
    Sadaka, Shiori
    Ajisawa, Kanae
    Okumura, Naoki
    Makiyama, Akitaka
    Iihara, Hirotoshi
    Yasufuku, Itaru
    Ohata, Koichi
    Kobayashi, Ryo
    Tanaka, Yoshihiro
    Hayashi, Hideki
    Suzuki, Akio
    ANTICANCER RESEARCH, 2022, 42 (09) : 4581 - 4588
  • [34] Prognostic factors in advanced gastric cancer patients (PTS) treated with a second-line chemotherapy
    Catalano, V
    Graziano, F.
    Santini, D.
    D'Emidio, S.
    Baldelli, A.
    Vincenzi, B.
    Giordani, P.
    Rossi, D.
    Alessandroni, P.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII24 - VII25
  • [35] Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel - Cisplatin
    Polyzos, Aristides
    Tsavaris, Nikolas
    Kosmas, Christos
    Polyzos, Kostas
    Giannopoulos, Athanasios
    Felekouras, Evangelos
    Nikiteas, Nikolas
    Kouraklis, Gregory
    Griniatsos, John
    Safioleas, Michael
    Stamatakos, Michael
    Pikoulis, Emmanuel
    Papachristodoulou, Antonios
    Gogas, Helen
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3749 - 3753
  • [36] Weekly paclitaxel for the second-line treatment of recurrent and advanced gastric cancer (RAGC)
    Cho, H
    Shotsu, A
    Konishi, K
    Kanari, M
    Tsuburaya, A
    Kobayashi, O
    Sairenji, M
    Motohashi, H
    Imada, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 428 - 428
  • [37] Optimal indications for second-line chemotherapy in advanced gastric cancer.
    Hasegawa, Hiroko
    Fujitani, Kazumasa
    Nakazuru, Shoichi
    Hirao, Motohiro
    Mita, Eiji
    Tsujinaka, Toshimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)
    Sato, Sho
    Kunisaki, Chikara
    Tamura, Yuko
    Yago, Akikazu
    Kasahara, Kohei
    Sato, Tsutomu
    Kondo, Hiroki
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (12) : 5663 - 5669
  • [39] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] Review of second-line chemotherapy for advanced gastric adenocarcinoma
    Wilson, D
    Hiller, L
    Geh, JI
    CLINICAL ONCOLOGY, 2005, 17 (02) : 81 - 90
12345